For the Inventor, By the Inventor

Enter assignee name

Oss, Netherlands

N.v. Organon

USPTO Granted Patents = 101

CIPO Patents = 18

EPO Patents = 31

Trademarks = 81

Forward Citations = 336

Loading Chart...

Loading Chart...

196 inventors (with patents filed for the assignee):

Cornelis Marius Timmers (10 out of 18 patents)

Hubert Jan Jozef Loozen (8 out of 18 patents)

Simon James Anthony Grove (6 out of 10 patents)

4. Neeltje Miranda Teerhuis (6 out of 7 patents)

5. Julia Adam-Worrall (6 out of 6 patents)

6. Zoran Rankovic (6 out of 6 patents)

7. Susan Elizabeth Napier (6 out of 6 patents)

8. Gerrit Herman Veeneman (5 out of 10 patents)

9. Jiaqiang Cai (5 out of 6 patents)

10. Gerardus Johannes Kemperman (5 out of 8 patents)

11. John Richard Morphy (5 out of 8 patents)

12. Pedro Harold Han Hermkens (4 out of 8 patents)

13. Willem Frederik Johan Karstens (4 out of 9 patents)

14. Herman Thijs Stock (4 out of 6 patents)

15. Jaap Van Der Louw (4 out of 17 patents)

Core Competencies:

Fully Human Antibodies

Non-Steroidal Androgens

Selective Enzymatic Amidation

Progesterone Receptor Modulators

Tetrahydronaphthalen-2-Ol Derivatives

Dihydropyridine Derivatives

FAAH Inhibitors

Indole Derivatives

Crystal Form of Asenapine Maleate

Tricyclic Piperazine Derivatives

Estrogenic Compounds

Cannabinoid Receptor Agonists

101 patents: Sort by Forward Citations

1. 8563694 - Fully human antibodies to BTLA (2013-10-22),

2. 8124647 - Non-steroidal androgens compounds (2012-02-28),

3. 8124372 - Selective enzymatic amidation of C-terminal esters or acids of peptides (2012-02-28),

4. 8106007 - Conjugates of a polypeptide and a pentasaccharide (2012-01-31),

5. 8071589 - Dihydrobenzoindazoles (2011-12-06),

6. 8071587 - (Dihydro)imidazoiso[5,1-A]quinolines (2011-12-06),

7. 8063102 - Tetrahydronaphthalen-2-ol derivatives (2011-11-22),

8. 8063037 - Progesterone receptor modulators (2011-11-22),

9. 8058441 - Tetrahydroquinoline derivatives (2011-11-15),

10. 8058436 - Method for the preparation of enantiomerically pure mirtazapine (2011-11-15),

11. D647295 - Slide case tablet dispenser (2011-10-25),

12. 8034945 - 4-phenyl-5-OXO-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility (2011-10-11),

13. 8034804 - (Pyrido/thieno)-[f]-oxazepine-5-one derivatives (2011-10-11),

14. D645658 - Slide case tablet dispenser (2011-09-27),

15. 8026236 - 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives (2011-09-27),

N.V. Organon is a global pharmaceutical company dedicated to improving the health and well-being of people worldwide. With a focus on innovative research and development, Organon strives to develop new therapies to address unmet medical needs. As a leader in women's health, Organon is committed to providing solutions for reproductive and maternal health. With a vast portfolio of products, Organon aims to make a positive impact in the lives of patients and healthcare professionals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

101 Patents

#1 in Oss

#89 in Netherlands

#7,500 in the World

Oss, Netherlands

N.v. Organon

Forward Citations = 336

196 inventors:

Cornelis Marius Timmers (10 out of 18 patents)

Hubert Jan Jozef Loozen (8 out of 18 patents)

Simon James Anthony Grove (6 out of 10 patents)

4. Neeltje Miranda Teerhuis (6 out of 7 patents)

5. Julia Adam-Worrall (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…